Abstract
This article describes the synthesis of 3,4-disubstituted-6,7-dihydro-imidazo[2,1-b][1,3]thiazoles and 3,4-disubstituted-7,8-dihydro-6H-imidazo[2,1-b][1,3]thiazines, having substituted or nonsubstituted phenyl rings at the 5,6 and 2,3 positions, respectively, their cytotoxic effects through noncancer (F2408) and cancer (5RP7) cells, and their detailed 1H- and 13C-nuclear magnetic resonance (NMR) spectral characterization. The title compounds were obtained by the cyclization of 4,5-diaryl-imidazole-2-thione and dihaloalkane (i.e., 1,2-dihaloethane or 1,3-dihalopropane), in the presence of potassium carbonate (K2CO3) in N,N-dimethyl formamide (DMF). 4,5-Diaryl-imidazole-2-thione was prepared by condensation of α-hydroxyketones (acyloins), which were obtained by treating aldehydes with cyanide, with thioureas in AcOH. The structure of imidazo[2,1-b][1,3]thiazole and imidazo[2,1-b][1,3]thiazine derivatives was confirmed by infrared (IR), 1H-NMR, and 13C-NMR. The cytotoxicities of the synthesized compounds on both of noncancer (F2408) and cancer (5RP7) cells were measured by 3-(4,5-dimethyl-thiazollyl-2)-2,5-diphenyltetrazolium (MTT) assay. In the presence of only lower doses of compounds 9 and 11, bearing methyl or methoxy substituents on the phenyl ring of imidazo[2,1-b][1,3]thiazole scaffold, the cytotoxic effect was higher on 5RP7 cells than control cells after 24 h.
Similar content being viewed by others
References
Andreani A, Rambaldi M, Leoni A, Locatelli A, Bossa R, Chiericozzi M, Galatulas I, Salvatore G (1996) Synthesis and cardiotonic activity of imidazo[2,1-b]thiazoles bearing a lactam ring. Eur J Med Chem 31:383–387
Andreani A, Rambaldi M, Leoni A, Morigi R, Locatelli A, Giorgi G, Lenaz G, Ghelli A, Esposti MD (1999) 6-Thienyl and 6-phenylimidazo[2,1-b]thiazoles as inhibitors of mitochondrial NADH dehydrogenase. Eur J Med Chem 34:883–889
Andreani A, Leoni A, Locatelli A, Morigi R, Rambaldi M, Simon WA, Senn-Bilfinger J (2000) Synthesis and antisecretory activity of 6-substituted 5-cyanomethylimidazo[2,1-b]-thiazoles and 2,6-dimethyl-5-hydroxymethyl imidazo[2,1-b][1,3,4]thiadiazole. Arzneim-Forsch-Drug Res 50:550–553
Andreani A, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Lenaz G, Fato R, Bergamini C, Farruggia G (2005a) Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2′,3′:2,3]imidazo[4,5-c]quinoline. J Med Chem 48:3085–3089
Andreani A, Granaiola M, Guardigli M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Roda A (2005b) Synthesis and chemiluminescent high throughput screening for inhibition of acetylcholinesterase activity by imidazo[2,1-b]thiazole derivatives. Eur J Med Chem 40:1331–1334
Athen B, Guglielmi H (1969) Metabolic properties of tumor slices under the influence of cytostatic compounds. Hoppe-Seyler’s Z Physiol Chem 350:803–808. (C.A., 71, 59266k)
Auerbach SS, Stoner MA, Su SZ, Omiecinski C (2005) Retinoid X receptor-alpha-dependent transactivation by a naturally occurring structural variant of human constitutive androstane receptor (NR1I3). J Mol Pharmacol 68:1239–1253
Bagrii AK, Galenko GF, Kochergin PM (1975) Synthesis of [1,3]thiazino[3,2-a]imidazole and its condensed analogs. Dopovidi Akademii Nauk Ukrains’koi RSR, Seriya B: Geologiya Geofizika Khimiya ta Biologiya 9:801–804
Bender PE (1978) 2,3-Dihydroimidazo[2,1-b]thiazoles. DE Patent 2742725 issued on March 30, 1978
Bender PE (1981) 5,6-Diphenyl-2,3-dihydroimidazo[2,1-b]thiazoles. US Patent 4263311 issued on April 21, 1981
Bender PE, Gleason JG, Griswold DE, Hanna N, Lantos I, Razgaitis KA, Sarau HM, Shilcrat SC (1992) Inhibition of the 5-lipoxygenase pathway. US Patent 5134150 issued on July 28, 1992
Bender PE, Hill D, Offen PH, Razgaitis K, Lavanchy P, Stringer OD, Sutton BM, Griswold DE, DiMartino M, Walz DT, Lantos I, Ladd CB (1985) 5,6-Diaryl-2,3-dihydroimidazo[2,1-b]thiazoles: a new class of immunoregulatory antiinflammatory agents. J Med Chem 28:1169–1177
Broom NJP, Harrington FP (2003) 6-(substituted methylene) penems and intermediates. US Patent 6600035 (B1) issued on July 29, 2003
Cesur Z, Güner H, Ötük G (1994) Synthesis and antimycobacterial activity of new imidazo[2,1-b]thiazole derivatives. Eur J Med Chem 29:981–983
Cheng HY, Davis LL, Bender PE, Gleason J (1989) Electrochemical investigations of anti-inflammatory agents 5,6-substituted-2,3-dihydroimidazo[2,1-b]thiazoles. J Electrochem Soc 136: 3679–3683
Cherkofsky SC, Sharpe TR (1977) Antiinflammatory diarylimidazothiazoles and their corresponding S-oxides. US Patent 4064260 – issued on Dec 20, 1977
Çapan G, Ulusoy N, Ergenç N, Kiraz M (1999) New 6-phenylimidazo[2,1-b]thiazole derivatives: Synthesis and antifungal activity. Monatsh Chem 130:1399–1407
Dou HJM, Ludwikow M, Hassanaly P, Kister J, Metzger J (1980) Synthesis of heterocycles by phase-transfer catalysis. J Het Chem 17:393–395
Fatimi J, Lagorce JF, Chabernaud ML, Comby F, Buxeraud J, Raby C (1993) Structure-activity relations of 1,4,5-trialkyl-2-thioimidazole towards the biological activity of thyroperoxidase. Bull Soc Pharm Bordeaux 132:53–64 (C.A., 121, 169756d)
Feil VJ, (1996) Synthesis of C-14-Labeled levamisole and C-13-labeled tetramisole. J Labelled Compd Radiopharm 38:1071–1076
Gadad AK, Mahajanshetti CS, Nimbalkar S, Raichurkar A (2000) Synthesis and antibacterial activity of some 5-guanylhydrazone/thiocyanato-6-arylimidazo[2,1-b]-1,3,4-thiadiazole-2-sulfonamide derivatives. Eur J Med Chem 35:853–857
Garbisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, Khoury G, Liotta LA (1987) Secretion of type IV collogenolytic protease and metastatic phenotype: Induction by transfection with c-HA-ras but not c-Ha-ras plus Ad2-Ela. Cancer Res 47:1523–1528
Goeschke R, Ferrini PG (1980) Bicyclic thiadiaza compounds and their use as medicaments. GB Patent 2039882 issued on August 20, 1980
Gregoire J, Girard P, Barbaud J (1951) Sun-ray protective substances. I. 4,5-Diphenyl-2(3H)-imidazolone, di-Na salt of 4,5-bis(p-sulfophenyl)-2(3H)-imidazolone, 4,5-diphenyl-2-mercaptoimidazole, and isobutyl p-dimethylamino benzoate. Ann Pharm Franç 9:493–513 (C.A., 46, 2752i)
Guglielmi H (1968) Cytostatic thymine derivatives of imidazole-2-thione. Z Physiol Chem 349:1733–1738 (C.A., 70, 68301z)
Gupta RP, Pujari HK (1978) Heterocyclic systems containing a bridgehead nitrogen atom: Part XXX. Reaction of 2-mercapto-4,5-dianisylimidazole with chloroacetic acid and alkyl halides. Indian J Chem Sect B 16B:329–331
Gürsoy E, Ulusoy-Güzeldemirci N (2007) Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives. Eur J Med Chem 42:320–326
Ide WS, Buck JS (1948). In “Organic Reactions”; R. Adams, Ed.; Wiley: NewYork, NY; Chapter 5
Jiang B, Liu Y, Bao M, An LJ (2003) Hydrogen peroxide-induced apoptosis in pc12 cells and the protective effect of puerarin. Cell Biol Int 27:1025–1031
Kiec-Kononowicz K, Karolak-Wojciechowska J, Muller CE, Schumacher B, Pekala E, Szymanska E (2001) Imidazo-thiazine, -diazinone and -diazepinone derivatives. Synthesis, structure and benzodiazepine receptor binding. Eur J Med Chem 36:407–419
Kolbe L, Pfannenbecker U, Kruse I, Sokolowski T, Immeyer J, Tom DK, Dannhardt G (2005) Novel Topical use of bis-arylimidazo[1,2-a]thiolane derivatives as antiinflammatory agents. EP Patent 1569612 issued on September 07, 2005
Kolmar Laboratories, Inc (1973) Antimicrobial and cytostatic thio ethers. DE Patent 2210230 issued on September 06, 1973
Kovpak DV, Bagrii AK (1970) Reaction of 2(8)-mercapto-heterocycles with 1,3-dibromo- and 1,3-chlorobromopropane. Khim Issled Farm 33. (From: Ref. Zh Khim 1970, Abstr. No. 23Zh410)
Mazur IA, Kochergin PM, Fomenko VI (1969) Synthesis of 2,3-dihydro- and 2,3,5,6-tetrahydro-derivatives of imidazo[2,1-b]thiazole. Khimiko-Farmatsevticheskii Zhurnal 3:11–15
Metabio-Fr (1977) 2,3-Dihydroimidazo[2,1-b]thiazole. DE Patent 2709639 issued on September 15, 1977
Mohan J, Chadha VK, Pujari HK (1973) Heterocyclic systems containing a bridgehead nitrogen atom. XVII. Reaction of 2-mercapto-4,5-diphenylimidazole with halo acids, α-halo ketones, alkyl halides, and 2,3-dichloroquinoxaline. Indian J Chem 11:747–749
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Or YS, Luly JR, Wagner R (1996) Macrolide immunomodulators. US Patent 5527907 issued on June 18, 1996
Özbey S, Meriç A (2006) 3,4-Di-p-tolyl-6,7-dihydro-imidazo[2,1-b][1,3]thiazole. Acta Crystallogr Sect E 62:2717–2719
Palagiano F, Arenare L, Luraschi E, Decaprariis P, Abignente E, Damico M, Filippelli W, Rossi F (1995) Research on heterocyclic compounds. 34. Synthesis and SAR study of some imidazo[2,1,b]thiazole carboxylic and acetic-acids with antiinflammatory and analgesic activities. Eur J Med Chem 30:901–909
Peterlin-Masic L, Malesic M, Breznik M, Krbavcic A (2000) Synthesis of new functionalized imidazo[2,1-b]thiazoles and thiazolo[3,2-a]pyrimidines. J Het Chem 37:95–101
Pooru EB, Jiyon JG, Don EG, Nabiru H, Iban R, Kaisu AR, Henrii MS, Suuzan KS (1987) Supperssion of 5-lipoxygenase route. Preparation of fused imidazole derivatives as 5-lipoxygenase inhibitors and drugs. JP Patent 62153286 issued on June 08, 1987
Rihiaruto G, Pieru JF (1979) Production of bicyclic thiadiaza compounds. JP Patent 54016470 issued on February 07, 1979
Schoeberl A, Magosch KH (1970) Cyclization reactions with 2-aminopenthiazoline. Reactivity of α-amino N-heterocycles. Justus Liebigs Annalen der Chemie 742:85–97
Skvortsova GG, Il’yuchenok TYu, Abramova ND, Frigidova LM, Shadurskii KS, Teterina LF, Trzhtsinskaya BV (1978) Synthesis and radioprotective properties of imidazolethione derivatives. Khim-Farm Zh 12:82–85 (C.A., 88, 170037b)
Terasawa K, Sugita Y, Yokoe I, Fujisawa S, Sakagami H (2001) Cytotoxic activity of 5-benzoylimidazole and related compounds against human oral tumor cell lines. Anticancer Res 21:1081–1086
Ulusoy N (2002) Synthesis and antituberculosis activity of cycloalkylidenehydrazide and 4-aza-1-thiaspiro[4.5]decan-3-one derivatives of imidazo[2,1-b]thiazole. Arzneim-Forsch-Drug Res 52:565–571
Ur F, Cesur N, Birteksöz S, Ötük G (2004) Synthesis of some new 6-methylimidazo[2,1-b]thiazole-5-carbohydrazide derivatives and their antimicrobial activities. Arzneim-Forsch-Drug Res 54:125–129
Weitzel G, Schneider F, Guglielmi H, Sander J, Durst J, Hirschmann WD (1966) Tumor inhibitors. III. Cytostatic effects of imidazole-2-thione and its derivatives. Hoppe-Seyler’s Z Physiol Chem 346:208–223; cf. CA. 61, 4864b (C.A., 66, 27566p)
Weitzel G, Schneider F, Guglielmi H, Seif F, Hirschmann WD, Durst J (1967) Tumor inhibitors. IV. Cytostatic and thyrostatic effects of thioethers of 2-mercaptoimidazole. Hoppe-Seyler’s Z Physiol Chem 348:1277–1284; cf. CA. 66, 27566p (C.A., 67, 107246v)
Yoshida Z, Masuda H, Oda R (1951) Synthesis of organic fluorescent compounds. III. Synthesis of the imidazolone derivatives from acyloins and urea. J Chem Soc Japan Ind Chem Sect 54:685–686 (C.A., 48, 2690h)
Acknowledgements
This study was supported in part by the Anadolu University Scientific Research Projects Foundation, AÜBAP, Eskişehir-TÜRKİYE (Project no. 990321/2000). The authors would like to thank AÜBAP and are grateful to the facilities of Anadolu University Medicinal and Aromatic Plant and Drug Research Center (AÜBİBAM, TR). They would also like to thank Novruz Akhmedov, PhD (University of Florida, Department of Chemistry, Gainesville) for his valuable contributions on the NMR analysis and Mutlu D. Aytemir, PhD (Hacettepe University, Department of Pharmaceutical Chemistry, Ankara-Türkiye) for her SciFinder screening study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meriç, A., İncesu, Z. & Hatipoğlu, İ. Synthesis of some 3,4-disubstituted-6,7-dihydro-imidazo[2,1-b][1,3]thiazole and 3,4-disubstituted-7,8-dihydro-6H-imidazo[2,1-b][1,3]thiazine derivatives and evaluation of their cytotoxicities against F2408 and 5RP7 cells. Med Chem Res 17, 30–41 (2008). https://doi.org/10.1007/s00044-008-9090-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-008-9090-7